136 related articles for article (PubMed ID: 8064701)
21. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
22. [Oestrogel--a transdermal and convenient method of hormone replacement therapy].
Krumov G
Akush Ginekol (Sofiia); 2003; 42 Suppl 1():17-20. PubMed ID: 12858498
[No Abstract] [Full Text] [Related]
23. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
Raudaskoski T; Knip M; Laatikainen T
Menopause; 1998; 5(4):217-22. PubMed ID: 9872487
[TBL] [Abstract][Full Text] [Related]
24. [Comparative evaluation of oral versus non-oral hormonal treatments in menopause].
Sitruk-Ware R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):688-93. PubMed ID: 8991902
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
26. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
[TBL] [Abstract][Full Text] [Related]
27. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
28. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
29. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
30. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women].
Araya V; Contreras P; Aguirre C; Foradori A
Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
32. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
[TBL] [Abstract][Full Text] [Related]
33. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience with a 7-day estrogen patch: principles and practice.
Notelovitz M
Gynecol Endocrinol; 1998 Aug; 12(4):248-58. PubMed ID: 9798134
[TBL] [Abstract][Full Text] [Related]
35. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
Fait T; Vrablik M; Zizka Z; Kostirova M
Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
[TBL] [Abstract][Full Text] [Related]
36. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
37. Body-identical hormone replacement.
Panay N
Climacteric; 2012 Apr; 15 Suppl 1():1-2. PubMed ID: 22432809
[No Abstract] [Full Text] [Related]
38. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
Archer DF
Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
[TBL] [Abstract][Full Text] [Related]
39. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
40. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]